Status:
UNKNOWN
Hemodynamic Effects of BPA at Rest and During Exercise in CTEPH
Lead Sponsor:
Aarhus University Hospital
Collaborating Sponsors:
Nagoya University
Department of Pulmonary Circulation and Thromboembolic Diseases, Medical Center for Postgraduate Med
Conditions:
Chronic Thromboembolic Pulmonary Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by obstruction of the pulmonary vasculature by residual organized thrombi, leading to increased pulmonary vascular resistance (PV...
Detailed Description
Chronic thromboembolic pulmonary hypertension \[CTEPH\] is a rare condition with a significant risk of morbidity and mortality. The primary cause of CTEPH is thrombotic lesions, which did not resolve ...
Eligibility Criteria
Inclusion
- Patients with CTEPH or CTED eligible for balloon pulmonary angioplasty.
Exclusion
- Patients unable to perform ergometer exercise
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04052243
Start Date
January 1 2021
End Date
June 30 2024
Last Update
July 20 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of cardiology, Aarhus University Hospital
Aarhus, Denmark, 8200
2
Nagoya University Hospital
Nagoya, Japan
3
European Health Center
Otwock, Poland